MGC Pharmaceuticals Overview

  • Founded
  • 2015
Founded
  • Status
  • Public
  • Stock Symbol
  • MXC
Stock Symbol
  • Investments
  • 5
  • Share Price
  • $0.05
  • (As of Friday Closing)

MGC Pharmaceuticals General Information

Description

MGC Pharmaceuticals Ltd is a biopharma company with a Nature to Medicine strategy within the international phytocannabinoid-derived and plant-derived medicines industry. Its operations comprise one segment, being production and supply of medicinal cannabis products. The company generates most of its revenue from Slovenia.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Stock Exchange
ASX
Primary Office
  • 1202 Hay Street West
  • Perth, Western Australia 6872
  • Australia
+61 (08) 0000 0000

MGC Pharmaceuticals Timeline

2018201920202021
Financing Round
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

MGC Pharmaceuticals Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.05 $0.05 $0.01 - $0.10 $113M 2.27B 25.4M

MGC Pharmaceuticals Financials Summary

In Thousands,
USD
TTM 31-Dec-2020 FY 2020 30-Jun-2020 FY 2019 30-Jun-2019 FY 2018 30-Jun-2018
EV 34,803 21,663 39,650 46,165
Revenue 718 1,393 469 230
EBITDA (8,436) (12,168) (1,295) (6,781)
Net Income (9,460) (12,970) (1,651) (6,388)
Total Assets 8,942 5,448 9,102 14,687
Total Debt 1,620 1,305 0 16
Public Fundamental Data provided by Morningstar, Inc. disclaimer

MGC Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore MGC Pharmaceuticals‘s full profile, request access.

Request a free trial

MGC Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
MGC Pharmaceuticals Ltd is a biopharma company with a Nature to Medicine strategy within the international phytocannabin
Pharmaceuticals
Perth, Australia
000.00
000000000 000.00

000000

on ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit i
0000 000000000
Tel Aviv, Israel
00 As of 0000
00000
00.00 0000-00-00
000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

MGC Pharmaceuticals Competitors (1)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
000000 Formerly VC-backed Tel Aviv, Israel 00 00000 000000000 00000
You’re viewing 1 of 1 competitors. Get the full list »

MGC Pharmaceuticals Executive Team (7)

Name Title Board Seat Contact Info
Roby Zomer Chief Executive Officer & Board Member
Itay Nissim Chief Operating Officer
Amir Polak Chief Technology Officer & Head, pharmaceutical production
Nicole Godresse Global Chief Sales Officer
Sasha Friedman Chief Product Officer
You’re viewing 5 of 7 executive team members. Get the full list »

MGC Pharmaceuticals Board Members (3)

Name Representing Role Since
0000 00000 MGC Pharmaceuticals Board Member 000 0000
00000 00000 MGC Pharmaceuticals Board Member 000 0000
0000 00000 MGC Pharmaceuticals Chief Executive Officer & Board Member 000 0000
To view MGC Pharmaceuticals’s complete board members history, request access »

MGC Pharmaceuticals Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore MGC Pharmaceuticals‘s full profile, request access.

Request a free trial

MGC Pharmaceuticals Investments & Acquisitions (5)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000 000000 0 00000 01-Nov-2019 00000 0000000 Specialty Retail 0000 00000
000 00000 27-Sep-2018 000000000 00000000 00000 Personal Products
00000 000000 07-Feb-2017 000000000000000000 00.00 Other Pharmaceuticals and Biotechnology 00000 00000
000 00000 01-May-2016 00000 0000000 Personal Products
Erin Mineral Resources 31-May-2012 Merger/Acquisition Gold Mining
To view MGC Pharmaceuticals’s complete investments and acquisitions history, request access »

MGC Pharmaceuticals Exits (3)

Company Name Exit Date Exit Type Exit Size Status Buyers
000 00000 27-Sep-2018 000000000 00000000 00000 Completed
  • 000 00000000000000
000 00000 01-May-2016 00000 0000000 Completed
  • 2 buyers
Erin Mineral Resources 31-May-2012 Merger/Acquisition Completed
To view MGC Pharmaceuticals’s complete exits history, request access »